Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

According to latest industry reports, the global Single-Use Bioprocessing Market is expected to expand significantly over the next decade, driven by increasing R&D activities, bio ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

PTP, a leader in cloud and managed services for the life sciences industry, is excited to announce the acquisition of Protocol Networks, a long-standing quality provider of managed IT services and IT ...